Tower Research Capital (TRC)’s XTL Biopharmaceuticals XTLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-153
| Closed | – | – | 6604 |
|
|
2021
Q4 | $0 | Buy |
+153
| New | – | ﹤0.01% | 6628 |
|
|
2016
Q4 | – | Sell |
-120
| Closed | -$1K | – | 4485 |
|
|
2016
Q3 | $1K | Hold |
120
| – | – | ﹤0.01% | 3386 |
|
|
2016
Q2 | $1K | Sell |
120
-40
| -25% | -$333 | ﹤0.01% | 4229 |
|
|
2016
Q1 | $1K | Buy |
160
+140
| +700% | +$875 | ﹤0.01% | 3810 |
|
|
2015
Q4 | $0 | Sell |
20
-60
| -75% | – | ﹤0.01% | 5141 |
|
|
2015
Q3 | $1K | Buy |
+80
| New | +$1K | ﹤0.01% | 3694 |
|
|
2015
Q1 | – | Sell |
-205
| Closed | -$2K | – | 5027 |
|
|
2014
Q4 | $2K | Sell |
205
-25
| -11% | -$244 | ﹤0.01% | 3404 |
|
|
2014
Q3 | $2K | Buy |
230
+83
| +56% | +$722 | ﹤0.01% | 3888 |
|
|
2014
Q2 | $2K | Buy |
147
+47
| +47% | +$639 | ﹤0.01% | 3472 |
|
|
2014
Q1 | $2K | Buy |
100
+30
| +43% | +$600 | ﹤0.01% | 3925 |
|
|
2013
Q4 | $1K | Buy |
+70
| New | +$1K | ﹤0.01% | 4267 |
|